Article
The Combination Therapy of Pasireotide LAR Plus Pegvisomant and Cabergoline Relieved Acromegaly-Related Headache in a Female Patient with AIP-Mutated Acromegaly: A Case Report
Endocrine, metabolic & immune disorders drug targets - 1 Jan 2026
Giambò Penelope, Chiloiro Sabrina, Giampietro Antonella, Mattogno Pier Paolo, Lauretti Liverana, De Marinis Laura, Bianchi Antonio, Doglietto Francesco, Pontecorvi Alfredo
Abstract excerpt
INTRODUCTION: Acromegaly is a rare condition characterized by excessive exposure to GH and IGF-1 due to a pituitary adenoma in most cases. The disease is associated with numerous symptoms, including headaches, which are frequently difficult to manage. CASE PRESENTATION: We report the clinical history of an 11-year-old female patient with an AIP mutation and acromegaly, who was unresponsive to treatment with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.